Tilray Brands, Inc. (TLRY)
Nasdaq: TLRY · Medicinal Chemicals & Botanical Products · New York, NY · filing with the SEC since 2018
Filings
435 filings since 2017 beside 335 insider forms · Large accelerated filer · read from EDGAR on Nov 13, 2026Due nextLarge accelerated filer
10-Q
Quarterly report for the quarter ending Nov 30, 2026Large accelerated filers have 40 days after the quarter ends; quarter ends are taken to the month end.
by Jan 9, 2027
10-K
Annual report for the fiscal year ending May 31, 2027Large accelerated filers have 60 days after the fiscal year ends.
by Jul 30, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 38 days after the quarter ended. The proxy statement was last filed Sep 28, 2026.
Filings a yearinsider forms included
831082068278685148
2026 counts to Nov 13, 2026.
Listing warning from its exchange (8-K item 3.01): 1 time in the last 36 months, the newest Mar 25, 2025.Officer or director change (8-K item 5.02): 1 time in the last 36 months, the newest Dec 13, 2024.SEC letters: 5 in the last 36 months, the newest Mar 18, 2026.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Mar 2, 2026
8-K items 1.01, 2.01, 8.01, 9.01
Major agreement signed; Purchase or sale of a business completed; Other event · Current report
Nov 26, 2025
8-K items 3.03, 5.03, 8.01, 9.01
Change to shareholders' rights; Charter, bylaw or fiscal-year change; Other event · Current report
40 of 435 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.